A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings
Author:
Affiliation:
1. ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA
2. ViiV Healthcare, P.T.M., Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain
3. ViiV Healthcare, 980 Great West Road, Brentford TW8 9GS, Middlesex, UK
Abstract
Funder
ViiV Healthcare
Publisher
MDPI AG
Subject
Virology,Infectious Diseases
Link
https://www.mdpi.com/1999-4915/15/12/2426/pdf
Reference90 articles.
1. European AIDS Clinical Society (2023, October 31). Guidelines Version 12.0. Available online: https://www.eacsociety.org/guidelines/eacs-guidelines/.
2. Optimizing antiretroviral therapy in treatment-experienced patients living with HIV: A critical review of switch and simplification strategies. An opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy;Chastain;J. Int. Assoc. Provid. AIDS Care,2019
3. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel;Gandhi;JAMA,2023
4. Nickel, K., Halfpenny, N.J.A., Snedecor, S.J., and Punekar, Y.S. (2021). Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: An update on a systematic review and network meta-analysis. BMC Infect. Dis., 21.
5. HIV treatment with the two-drug regimen dolutegravir plus lamivudine in real-world clinical practice: A systematic literature review;Patel;Infect. Dis. Ther.,2021
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics;Clinical Pharmacology & Therapeutics;2024-07-16
2. Paediatric antiretroviral therapy challenges with emerging integrase resistance;Current Opinion in HIV and AIDS;2024-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3